The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Silva Francisco since 2017.
This trader's CIK number is 1527241.
At the time of last reporting, Silva Francisco was the VP of Research and Development of Biorestorative Therapies, Inc.. (stock ticker symbol BRTX).
Also see all insider trading activities at Biorestorative Therapies, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | BRTX | 8,308 | $10,214 | 0 | $0 | 0 | $0 |
| 2023 | BRTX | 5,701 | $13,656 | 0 | $0 | 0 | $0 |
| 2022 | BRTX | 7,254 | $24,338 | 3,958 | $13,409 | 0 | $0 |
| 2021 | BRTX | 11,826 | $79,281 | 0 | $0 | 0 | $0 |
| 2019 | BRTX | 63,829 | $16,356 | 0 | $0 | 0 | $0 |
| 2014 | BRTX | 4,245 | $19,348 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-04-08 | BRTX | Buy | 1,708 | 1.15 | 1,964 |
| 2024-04-09 | BRTX | Buy | 6,600 | 1.25 | 8,250 |
| 2023-08-31 | BRTX | Buy | 4,954 | 2.22 | 10,997 |
| 2023-03-31 | BRTX | Buy | 747 | 3.56 | 2,659 |
| 2022-10-11 | BRTX | Buy | 806 | 3.69 | 2,973 |
| 2022-10-12 | BRTX | Buy | 725 | 3.39 | 2,456 |
| 2022-08-26 | BRTX | Buy | 2,600 | 3.35 | 8,710 |
| 2022-08-29 | BRTX | Buy | 3,123 | 3.27 | 10,199 |
| 2022-08-26 | BRTX | Sale | 3,958 | 3.39 | 13,409 |
| 2021-11-19 | BRTX | Buy | 4,000 | 6.66 | 26,628 |
| 2021-11-16 | BRTX | Buy | 7,826 | 6.73 | 52,653 |
| 2019-09-04 | BRTX | Buy | 20,955 | .24 | 4,987 |
| 2019-08-30 | BRTX | Buy | 18,000 | .27 | 4,914 |
| 2019-08-26 | BRTX | Buy | 7,500 | .27 | 2,025 |
| 2019-08-22 | BRTX | Buy | 17,374 | .26 | 4,430 |
| 2014-06-10 | BRTX | Buy | 25 | 7.60 | 190 |
| 2013-12-26 | BRTX | Buy | 100 | 10.40 | 1,040 |
| 2017-02-02 | BRTX | Buy | 2,250 | 4.25 | 9,562 |
| 2014-06-11 | BRTX | Buy | 20 | 7.60 | 152 |
| 2013-07-17 | BRTX | Buy | 50 | 10.40 | 520 |
| 2017-02-09 | BRTX | Buy | 1,800 | 4.38 | 7,884 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Silva Francisco (VP of Research and Development of Biorestorative Therapies, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.